Risk factors for blood component therapy in parturients—Case–control study
International Journal of Gynecology & Obstetrics · 2023-09 · 162 (3) · 906-912
DOI: 10.1002/ijgo.14747 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2023-04. Verfasst von Daniel Gabbai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Obstetrics and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Placenta, Retained. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Postpartum hemorrhage is a major cause of maternal morbidity and mortality, so early identification of patients at risk is crucial. In this study, we aim to assess the risk factors for major transfusion in parturients.
Methods
A case–control study was conducted between 2011 and 2019. The cases included women who were treated with postpartum major transfusion compared with two control groups, one of which was treated with 1–2 packed red blood cells and one of which was not treated with packed red blood cells. Cases were matched with controls based on two variables: multiple pregnancies and previous history of three or more cesarean sections. A multivariable conditional logistic regression model was used to determine the role of the independent risk factors.
Results
Of the 187 424 deliveries included in the present study, 246 (0.3%) women were treated with major transfusions. After applying a multivariate analysis, maternal age (odds ratio [OR] 1.07, 95% confidence interval [CI] 0.996–1.16), antenatal anemia with hemoglobin less than 10 g/dL (OR 12.58, 95% CI 2.86–55.25), retained placenta (OR 5.5, 95% CI 2.15–13.78), and cesarean delivery (OR 10.12, 95% CI 0.93–1.95) remained independent risk factors for major transfusions.
Discussion
Retained placenta and antenatal anemia (hemoglobin < 10 g/dL) are independent risk factors for major transfusion. Of these, anemia was found to be the most significant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Obstetrics and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- School of Public Heath, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Division of Obstetrics and Gynecology, Maayanei Hayeshuah Medical Center, Bnei Brak, Israel.
- Women and Children's Health Research Unit, Gertner Institute, Tel-Hashomer, Israel.
ORCID-Profile: Daniel Gabbai
Zitieren
APA
Gabbai, D., Many, A., Lerner-Geva, L., & Attali, E. (2023). Risk factors for blood component therapy in parturients—Case–control study. International Journal of Gynecology & Obstetrics, 162(3), 906-912. https://doi.org/10.1002/ijgo.14747
Vancouver
Gabbai D, Many A, Lerner-Geva L, Attali E. Risk factors for blood component therapy in parturients—Case–control study. International Journal of Gynecology & Obstetrics. 2023;162(3):906-912. doi:10.1002/ijgo.14747
BibTeX
@article{Gabbai2023,
author = {Gabbai, Daniel and Many, Ariel and Lerner-Geva, Liat and Attali, Emmanuel},
title = {Risk factors for blood component therapy in parturients—Case–control study},
journal = {International Journal of Gynecology & Obstetrics},
year = {2023},
volume = {162},
number = {3},
pages = {906--912},
doi = {10.1002/ijgo.14747}
}
EUVIMED